Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative-stress regulatory gene: implications for sensitivity to isoniazid

Molecular Microbiology
Vojo DereticS T Cole

Abstract

The systems participating in detoxification of reactive oxygen intermediates in Mycobacterium tuberculosis are believed to play a dual role in the biology of this highly adapted human pathogen: (i) they may contribute to the survival of this bacterium in the host; and (ii) alterations in the gene encoding catalase/peroxidase have been linked to this organism's resistance to the front-line antituberculosis drug isoniazid. These relationships prompted us to extend investigations of the oxidative-stress-response systems in M. tuberculosis by analysing the alkyl hydroperoxide reductase gene ahpC and its putative regulator oxyR. Surprisingly, the oxyR gene was found to be inactivated by multiple lesions in M. tuberculosis H37Rv. These alterations were observed in all M. tuberculosis strains tested, and in members of the M. tuberculosis complex: Mycobacterium bovis BCG, Mycobacterium africanum, and Mycobacterium microti. The corresponding region carrying these genes in Mycobacterium leprae, an organism not sensitive to isoniazid, has a complete oxyR gene divergently transcribed from ahpC. An increase in minimal inhibitory concentration for isoniazid was observed upon transformation of M. tuberculosis H37Rv with cosmids carrying the o...Continue Reading

Citations

Nov 1, 1996·Trends in Microbiology·Y Zhang
Jan 7, 1998·Biochemical Pharmacology·C E Barry
Apr 3, 2001·International Journal of Antimicrobial Agents·S H Gillespie
Feb 1, 1997·International Journal of Antimicrobial Agents·B Heym, S T Cole
Sep 19, 1997·Trends in Microbiology·V DereticE Pagán-Ramos
Jul 8, 2000·Microbes and Infection·R A Slayden, C E Barry
Nov 2, 2002·Molecular Microbiology·Elaine O DavisErik C Böttger
Jan 16, 2010·The Journal of Biological Chemistry·Mohammad Rubayet HasanLacy Daniels
Jun 29, 2010·Antioxidants & Redox Signaling·Peng R ChenChuan He
Jan 20, 2012·Antioxidants & Redox Signaling·Andrés Vázquez-Torres
Jun 26, 2008·The Journal of Antimicrobial Chemotherapy·D M O'SullivanS H Gillespie
Jun 24, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J BrimnesG Houen
Jan 16, 2007·Antimicrobial Agents and Chemotherapy·Lynn G DoverLaurent Kremer
Jul 19, 2006·Clinical Microbiology Reviews·Digby F Warner, Valerie Mizrahi
Sep 10, 2002·Journal of Bacteriology·Ji-Sook HahnJung-Hye Roe
Mar 21, 2006·Journal of Bacteriology·Eileen Pagán-RamosVojo Deretic
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·Ying Zhang
May 30, 2002·Biological Chemistry·Birgit HofmannLeopold Flohé
Jun 11, 1998·Emerging Infectious Diseases·A RattanN Ahmad
Nov 12, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y ZhangV Deretic
Jan 7, 1998·The Journal of Experimental Medicine·S EhrtL W Riley
Nov 1, 2006·Molecular Microbiology·Graham S Timmins, Vojo Deretic

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Bacterial Respiration

This feed focuses on cellular respiration in bacteria, known as bacterial respiration. Discover the latest research here.

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.